Low-temperature molten salt synthesis and catalytic mechanism of CoS2/NC as an advanced bifunctional electrocatalyst.

The development of productive and sustainable bifunctional electrocatalysts for the oxygen reduction reaction (ORR) and oxygen evolution reaction (OER) plays an important role in the commercial evolution of metal-air batteries. In this paper, a low-temperature molten salt template method was adopted to synthesize the composite of CoS2 and nitrogen-doped carbon (CoS2/NC) without the protection of inert gas. The structural characterization studies show that the specific surface area (SSA) and crystal growth kinetics are increased and effectively improved, respectively, by the composite of CoS2 and NC. The as-synthesized CoS2/NC composite demonstrates outstanding bifunctional catalytic activity in alkaline electrolytes and exhibits a half-wave potential (E1/2) of 0.854 V (vs. RHE) and an overpotential of only 220 mV for the OER at a current density of 10 mA cm-2 (η10). Simultaneously, CoS2/NC also exhibits excellent electrochemical stability. Additionally, density functional theory (DFT) calculations have manifested that the synergistic effect of CoS2 and NC results in a remarkable enhancement in the bifunctional catalytic performance of the composite materials. This study offers a new pathway and theoretical guidance for the fabrication of efficient bifunctional electrocatalysts.

Expression of CD39 mRNA is altered in the peripheral blood of patients with allergic asthma.

The ectoenzyme CD39 hydrolyzes extracellular adenosine 5'-triphosphate (ATP), which possesses pro-inflammatory properties. However, the role of CD39 in allergic asthma has not been fully elucidated. A total of 18 patients with persistent asthma who were allergic to house dust mites and 19 healthy volunteers were enrolled in this study. The expression of CD39, GATA3, RAR-related orphan receptor γ (ROR-γt) and forkhead box P3 (FoxP3) mRNA in peripheral blood mononuclear cells (PBMCs) was determined by SYBR-Green I quantitative polymerase chain reaction (qPCR). The cytokines interleukin (IL)-4, IL-17A, transforming growth factor ß (TGF-ß) and DP.sIgE were detected by enzyme-linked immunosorbent assay. Our data demonstrated that the expression of CD39 mRNA in PBMCs from asthmatic patients was significantly lower compared to that in normal controls [(1.49±0.59)×10-3 vs. (2.17±0.77)×10-3, respectively; P<0.01]. CD39 mRNA was negatively correlated with serum IL-4, IL-17A and GATA3 expression (r=-0.468, P<0.05; r=-0.550, P<0.05; and r=-0.424, P<0.01, respectively) and positively correlated with FoxP3 and TGF-ß expression (r=0.373, P<0.05; and r=0.425, P<0.05, respectively). There was no obvious correlation between CD39 and ROR-γt expression (r=-0.259, P=0.122). These data suggested that CD39 mRNA expression was downregulated in allergic asthma, which was positively correlated with serum IL-4, IL-17A and GATA3 expression and negatively correlated with serum TGF-ß and FoxP3 expression, whereas there was no correlation with ROR-γt. Therefore, it was hypothesized that CD39 may participate in the occurrence and progression of allergic asthma.